Literature DB >> 3937758

A minor subset of HLA-DR3 haplotypes is preferentially increased in type 1 (insulin-dependent) diabetes.

M J Sheehy, J R Rowe, T C Fuller, E J Yunis, K H Gabbay.   

Abstract

We have been using human T-lymphocyte clones specifically sensitized to detect leucocyte antigens of Type 1 (insulin-dependent) diabetic patients in the hope of detecting novel HLA antigens associated with Type 1 diabetes. We previously described two such clones which define a new class II HLA antigen, Boston-1 (BO1). BO1 is found mainly on cells of persons with particular HLA-DR antigens and, of potential significance for diabetes, BO1 identifies a distinctive subset of DR3 haplotypes. We report here that BO1+ DR3 haplotypes are overrepresented in Type 1 diabetes. That is, significantly more of the DR3-positive subjects are BO1-positive in the patient group (31%) than in the control group (8%), suggesting that a diabetes-susceptibility gene may be more common on the BO1+ than on the BO1- DR3 haplotypes. Alternative interpretations are also discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937758     DOI: 10.1007/bf00703131

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  A METHOD FOR CLUSTER ANALYSIS.

Authors:  A W EDWARDS; L L CAVALLI-SFORZA
Journal:  Biometrics       Date:  1965-06       Impact factor: 2.571

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

3.  Genetic marker for insulin-dependent diabetes mellitus.

Authors:  D Raum; C A Alper; R Stein; K H Gabbay
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

4.  HLA-DR antigens and unique serologic reactions in juvenile-onset diabetes mellitus.

Authors:  M R Garovoy; J Barbosa; M Reddish; S Martin; H Noreen; E J Yunis; C B Carpenter
Journal:  Transplant Proc       Date:  1978-12       Impact factor: 1.066

5.  HLA-A, B, C, DR, Bf, and C2 alleles in insulin-dependent diabetes mellitus with proliferative retinopathy.

Authors:  J Bertrams; G Dewald; M Spitznas; C Rittner
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

6.  HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes.

Authors:  M J Sheehy; P M Sondel; M L Bach; R Wank; F H Bach
Journal:  Science       Date:  1975-06-27       Impact factor: 47.728

7.  A particular subset of HLA-DR4 accounts for all or most of the DR4 association in type I diabetes.

Authors:  M J Sheehy; J R Rowe; M J MacDonald
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

8.  Studies of the HLA system and insulin-dependent diabetes mellitus.

Authors:  M Christy; A Green; B Christau; H Kromann; J Nerup; P Platz; M Thomsen; L P Ryder; A Svejgaard
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  DR4 related antisera pattern differences in insulin dependent diabetes mellitus and rheumatoid arthritis.

Authors:  B D Tait; A Boyle; S Solty; T Cunningham; T Mandel; F I Martin; T Doran
Journal:  Tissue Antigens       Date:  1984-10

10.  HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals.

Authors:  D Owerbach; A Lernmark; P Platz; L P Ryder; L Rask; P A Peterson; J Ludvigsson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

View more
  5 in total

1.  Molecular analysis distinguishes two HLA-DR3-bearing major histocompatibility complex extended haplotypes.

Authors:  M Z Wescott; Z L Awdeh; E J Yunis; C A Alper
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 2.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.

Authors:  G Thomson; W P Robinson; M K Kuhner; S Joe; M J MacDonald; J L Gottschall; J Barbosa; S S Rich; J Bertrams; M P Baur
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

3.  Unusual clustering of diseases in a Canadian Old Colony (Chortitza) Mennonite kindred and community.

Authors:  M A Jaworski; J D Slater; A Severini; K R Hennig; G Mansour; J G Mehta; R Jeske; J Schlaut; C Y Pak; J W Yoon
Journal:  CMAJ       Date:  1988-06-01       Impact factor: 8.262

4.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.